{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Leverage",
        "Synthetic replication",
        "Swap usage",
        "Daily leveraged exposure",
        "Compounding effect"
    ],
    "classification": "complex",
    "supporting_data": "The product is a 3x leveraged ETP providing three times the daily performance of the Solactive US Artificial Intelligence Index. It uses a collateralised structure with margin accounts holding reference assets, cash, and ancillary assets. The document explicitly states the use of leverage (3x exposure), daily rebalancing causing compounding effects, and collateralised exchange traded securities, which implies synthetic replication. The product is not UCITS compliant and is classified as an ETP, not an ETF. The risk indicator is at the highest level (7/7), indicating very high risk. The product is intended for sophisticated investors able to monitor daily and understand leverage and compounding risks. There is no capital protection, and the product may lose all invested capital. The use of margin accounts and collateral assets, combined with the leverage and daily rebalancing, strongly suggests the use of derivatives and swap agreements to achieve the leveraged exposure. The KIID warns that the product is 'not simple and may be difficult to understand,' which aligns with MiFID II complexity criteria. No mention of inverse exposure, but the leverage and synthetic replication alone classify it as complex. The PRIIPs KID and fact sheet (though not fully provided here) would likely confirm derivative usage and complexity warnings. Overall, the product\u2019s synthetic leveraged structure, swap usage, and high risk profile drive the classification as complex under MiFID II."
}